Results
2251
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2251 companies
Universal Health Services
Market Cap: US$13.2b
Through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities.
UHS
US$206.84
7D
2.9%
1Y
-2.8%
Fisher & Paykel Healthcare
Market Cap: NZ$22.1b
Designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally.
FPH
NZ$37.65
7D
2.7%
1Y
8.8%
Solventum
Market Cap: US$12.8b
A healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally.
SOLV
US$73.78
7D
2.2%
1Y
11.3%
Ascendis Pharma
Market Cap: US$12.5b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.
ASND
US$210.83
7D
10.0%
1Y
51.5%
Encompass Health
Market Cap: US$12.4b
Provides post-acute healthcare services in the United States and Puerto Rico.
EHC
US$123.62
7D
-1.8%
1Y
31.4%
Cochlear
Market Cap: AU$18.6b
Provides implantable hearing solutions for children and adults worldwide.
COH
AU$284.80
7D
2.0%
1Y
-2.3%
Baxter International
Market Cap: US$12.3b
Through its subsidiaries, provides a portfolio of healthcare products in the United States.
BAX
US$23.15
7D
3.4%
1Y
-35.3%
Viatris
Market Cap: US$11.9b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$10.13
7D
5.3%
1Y
-10.6%
Hims & Hers Health
Market Cap: US$11.9b
Operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally.
HIMS
US$54.76
7D
-7.4%
1Y
181.7%
Moderna
Market Cap: US$11.1b
A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.
MRNA
US$27.54
7D
8.7%
1Y
-53.1%
Roivant Sciences
Market Cap: US$11.0b
A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.
ROIV
US$16.26
7D
7.7%
1Y
45.0%
Ionis Pharmaceuticals
Market Cap: US$11.0b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$69.02
7D
7.6%
1Y
82.3%
Molina Healthcare
Market Cap: US$10.9b
Provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces.
MOH
US$200.57
7D
3.9%
1Y
-38.3%
Revvity
Market Cap: US$10.9b
Provides health sciences solutions, technologies, and services.
RVTY
US$93.38
7D
10.9%
1Y
-23.8%
Exelixis
Market Cap: US$10.8b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$40.01
7D
-1.4%
1Y
52.1%
Exact Sciences
Market Cap: US$10.7b
Provides cancer screening and diagnostic test products in the United States and internationally.
EXAS
US$57.63
7D
8.0%
1Y
-16.8%
BioMarin Pharmaceutical
Market Cap: US$10.6b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$55.61
7D
2.9%
1Y
-19.4%
Elanco Animal Health
Market Cap: US$10.3b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$20.66
7D
5.4%
1Y
42.0%
Qiagen
Market Cap: US$10.1b
Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.
QGEN
US$46.96
7D
6.9%
1Y
5.4%
BridgeBio Pharma
Market Cap: US$10.1b
A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.
BBIO
US$54.61
7D
5.1%
1Y
119.8%
Ensign Group
Market Cap: US$10.0b
Provides skilled nursing, senior living, and rehabilitative services.
ENSG
US$177.22
7D
3.3%
1Y
23.5%
Penumbra
Market Cap: US$10.0b
Designs, develops, manufactures, and markets medical devices in the United States and internationally.
PEN
US$255.61
7D
1.6%
1Y
34.0%
Madrigal Pharmaceuticals
Market Cap: US$9.9b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$442.31
7D
-0.2%
1Y
105.9%
Bio-Techne
Market Cap: US$9.8b
Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.
TECH
US$61.92
7D
18.6%
1Y
-15.8%
Avantor
Market Cap: US$9.7b
Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
AVTR
US$14.09
7D
19.0%
1Y
-43.6%
Align Technology
Market Cap: US$9.6b
Provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally.
ALGN
US$131.50
7D
4.1%
1Y
-44.0%
DaVita
Market Cap: US$9.4b
Provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.
DVA
US$128.14
7D
-1.9%
1Y
-18.7%
Corcept Therapeutics
Market Cap: US$9.3b
Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$89.85
7D
7.1%
1Y
101.2%
Verona Pharma
Market Cap: US$9.2b
A biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs.
VRNA
US$106.79
7D
0.2%
1Y
233.2%
Caris Life Sciences
Market Cap: US$8.9b
An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
CAI
US$32.81
7D
9.4%
1Y
n/a
Revolution Medicines
Market Cap: US$8.7b
A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.
RVMD
US$46.58
7D
1.1%
1Y
-1.6%
Charles River Laboratories International
Market Cap: US$8.7b
Charles River Laboratories International, Inc.
CRL
US$174.95
7D
19.0%
1Y
-7.5%
Jazz Pharmaceuticals
Market Cap: US$8.5b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$137.58
7D
6.6%
1Y
26.8%
Regencell Bioscience Holdings
Market Cap: US$8.5b
Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.
RGC
US$17.25
7D
5.2%
1Y
14,797.8%
Repligen
Market Cap: US$8.4b
A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.
RGEN
US$150.10
7D
21.0%
1Y
9.9%
Globus Medical
Market Cap: US$8.2b
A medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.
GMED
US$60.17
7D
6.6%
1Y
-13.9%